An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease

R A Cooper, M Diloy Puray, P Lando, M S Greenverg, R A Cooper, M Diloy Puray, P Lando, M S Greenverg

Abstract

Most patients with stable cirrhosis of the alcoholic have "target" red cells; however, a minority have "spur" cells and severe hemolytic anemia. These two syndromes were studied in 27 patients with target cells and 17 patients with spur cells, all of whom had advanced cirrhosis. The cholesterol and phospholipid content of red cell membranes effectively distinguished target cells from spur cells. Target cells alone were rich in lecithin, and both the cholesterol/phospholipid and cholesterol/lecithin mole ratios were greater in spur cells. The cholesterol/phospholipid mole ratio of both types of red cells correlated closely with the free cholesterol saturation of serum lipoproteins, as defined by the amount of free cholesterol relative to phospholipid and protein in these lipoproteins. Lecithin: cholesterol acyltransferase (LCAT) activity was decreased in most patients with target cells and spur cells; however, the relationship between this activity and the lipid abnormalities observed was weak. Serum bile acid levels also correlated poorly with serum and cell lipids. However, in patients with target cells the amount of cholic and deoxycholic acids in serum was approximately equal to the amount of chenodeoxycholic acid, whereas in patients with spur cells chenodeoxycholic acid (the precursor of lithocholic acid) predominated.

References

    1. Biochem J. 1964 Feb;90(2):374-8
    1. Science. 1965 Oct 29;150(3696):620-2
    1. J Biol Chem. 1966 Jan 25;241(2):469-76
    1. Scand J Clin Lab Invest. 1966;18(2):209-16
    1. N Engl J Med. 1966 Sep 22;275(12):639-43
    1. Medicine (Baltimore). 1966 Nov;45(6):461-70
    1. J Clin Invest. 1967 Mar;46(3):357-68
    1. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1220-4
    1. Gastroenterology. 1967 Nov;53(5):790-3
    1. J Clin Invest. 1967 Nov;46(11):1855-66
    1. J Clin Invest. 1968 Apr;47(4):749-60
    1. J Clin Invest. 1968 Apr;47(4):809-22
    1. J Lipid Res. 1968 Mar;9(2):155-67
    1. J Lab Clin Med. 1968 Mar;71(3):438-47
    1. Scand J Clin Lab Invest. 1968;21(4):327-32
    1. J Clin Invest. 1969 Apr;48(4):736-44
    1. Biochim Biophys Acta. 1969 Jan 28;173(1):141-2
    1. J Clin Invest. 1969 May;48(5):906-14
    1. Br Med J. 1969 May 3;2(5652):283-6
    1. Anal Biochem. 1969 Apr 11;29(1):164-6
    1. Gastroenterology. 1969 Jun;56(6):1033-9
    1. J Clin Invest. 1969 Oct;48(10):1820-31
    1. J Clin Invest. 1969 Dec;48(12):2398-408
    1. Blood. 1969 Dec;34(6):739-46
    1. Clin Chim Acta. 1970 Jan;27(1):185-96
    1. Biochim Biophys Acta. 1970 Feb 10;202(1):202-5
    1. Scand J Clin Lab Invest. 1969 Sep;24(2):187-96
    1. Acta Med Scand. 1970 Mar 3;187(3):153-61
    1. Trans Assoc Am Physicians. 1969;82:324-30
    1. Proc Soc Exp Biol Med. 1970 Jul;134(3):797-9
    1. J Clin Invest. 1970 Sep;49(9):1668-78
    1. Br J Haematol. 1970 Aug;19(2):223-35
    1. N Engl J Med. 1970 Oct 15;283(16):841-6
    1. Acta Med Scand. 1970 Oct;188(4):323-6
    1. J Clin Invest. 1971 Feb;50(2):259-65
    1. J Lab Clin Med. 1971 Jan;77(1):122-33
    1. Am J Med. 1971 Feb;50(2):218-32
    1. J Lipid Res. 1970 Nov;11(6):528-35
    1. Eur J Clin Invest. 1971 May;1(5):352-60
    1. J Lab Clin Med. 1971 Jun;77(6):891-900
    1. J Lab Clin Med. 1971 Sep;78(3):323-35
    1. J Lab Clin Med. 1972 Jan;79(1):7-18
    1. Proc Soc Exp Biol Med. 1951 Oct;78(1):329-32
    1. J Biol Chem. 1951 Nov;193(1):265-75
    1. J Lab Clin Med. 1953 Mar;41(3):486-92
    1. J Clin Invest. 1953 Sep;32(9):801-6
    1. J Clin Invest. 1955 Mar;34(3):390-404
    1. J Clin Invest. 1955 Sep;34(9):1345-53
    1. Ann Intern Med. 1956 Dec;45(6):1027-44
    1. J Clin Invest. 1957 Apr;36(4):530-7
    1. J Clin Invest. 1958 Nov;37(11):1494-503
    1. J Biol Chem. 1959 Mar;234(3):466-8
    1. J Clin Invest. 1960 Nov;39:1639-50
    1. Ann Intern Med. 1963 Jun;58:977-88
    1. Proc Soc Exp Biol Med. 1963 May;113:139-42
    1. Pharmacol Rev. 1963 Mar;15:123-67
    1. N Engl J Med. 1964 Aug 20;271:396-8
    1. J Clin Invest. 1964 Nov;43:2048-62
    1. Q J Med. 1965 Jan;34:33-64
    1. J Lipid Res. 1965 Apr;6:182-92
    1. J Lipid Res. 1965 Jul;6:397-410
    1. J Lipid Res. 1965 Jul;6:428-31

Source: PubMed

3
구독하다